Safety, Tolerability and Pharmacodynamics of BIIF 1149 BS in Healthy Young Male Volunteers
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The objective of the present study is to obtain information about the safety and tolerability
of BIIF 1149 BS, to determine the pharmacologically active dose (range) by performing a
citric acid challenge test and to obtain preliminary pharmacokinetic data